Legal & disclosures
Review-draft disclosures for the REGNR8 website, product demonstration and investor-access pathway.
REGNR8™ is the flagship governed health-intelligence platform of Executive Athlete Lab (Pty) Ltd.
01
REGNR8 provides educational, interpretive and coaching-support infrastructure. It does not diagnose, prescribe, treat, cure, prevent disease, change medication, replace qualified care or provide emergency support. Product demonstrations use synthetic or rigorously de-identified material and must not be used for clinical decision-making.
02
This website is for general information and confidential investor discussion only. It is not an offer of securities, investment advice, legal advice, tax advice, accounting advice, medical advice or a guarantee of product performance or investor return.
03
Statements concerning plans, milestones, markets, product development, pilots, revenue assumptions, financing, corporate structure or future performance are forward-looking, uncertain and subject to risks. Actual outcomes may differ materially because of execution, financing, commercial, regulatory, legal, privacy, technology, claims, market and other factors.
04
Nothing on this website constitutes an offer to sell, invitation to subscribe for or solicitation of an offer to buy securities in any jurisdiction. Expressions of interest do not create an allocation, reservation, commitment or right to participate.
05
REGNR8 and Executive Athlete Lab do not provide investment, legal, tax or accounting advice through this website. Prospective investors must conduct their own diligence and obtain independent professional advice.
06
Do not submit personal health information, patient information or clinical records through investor forms. Data collection, storage, access, retention, cross-border handling and deletion must be governed by the final published privacy notice and implemented controls. See the Privacy & Data Handling page.
07
Demo content is illustrative, non-clinical and provided only to explain the proposed operating system. It must not be relied on as medical, commercial, technical or investment proof and may change before production release.
08
Investor materials may be released only after eligibility review, NDA where required and management approval. Materials may be watermarked and access logged. Access does not create an offer, allocation or entitlement.
09
Information may not be lawful, appropriate or available in every jurisdiction. No person should access or act on investor materials where doing so would breach applicable law. Any discussion remains subject to jurisdiction-specific legal and securities-law review.